Monoclonal antibody 1BE12 immunoreactivity with human endometrium. Correlations with hormone receptors and...

Area of Science:

• Gynecologic Oncology
• Immunohistochemistry
• Cancer Biomarkers

Background:

• Monoclonal antibody (MAb) 1BE12 shows differential reactivity with human tissues, including stronger reactions with endometrial carcinomas compared to normal tissue.
• Investigating MAb 1BE12's potential for identifying cell proliferation in endometrial cancers is crucial for improving diagnostic accuracy.

Purpose of the Study:

• To evaluate the effectiveness of MAb 1BE12 immunocytochemical assays (ICAs) for detecting and grading endometrial carcinoma.
• To assess the correlation of MAb 1BE12 immunoreactivity with cell proliferation markers and hormone receptors.

Main Methods:

• 1BE12 ICAs were performed on frozen (n=47) and paraffin-embedded (n=100) endometrial biopsy specimens.
• Computer-assisted microcytophotometry (SAMBA) was used to quantify MAb 1BE12 immunoprecipitate distribution.
• Immunoreactivity was compared with cell proliferation markers (Ki67, EGFR, pHER-2/neu, cathepsin) and hormone receptors (estrogen, progesterone).

Main Results:

• MAb 1BE12 immunoreactivity was preserved in paraffin-embedded tissues and correlated positively with cell proliferation and malignancy grade.
• Immunostaining was significantly higher in invasive carcinomas than in normal proliferative endometrium and endometrial hyperplasia.
• No correlation was found between MAb 1BE12 and estrogen/progesterone receptor status, but it correlated with Ki67, EGFR, pHER-2/neu, and cathepsin.

Conclusions:

• MAb 1BE12 is a valuable marker for assessing cell proliferation in endometrial biopsy specimens.
• Combined with other markers, MAb 1BE12 ICAs can aid in the early detection and grading of endometrial carcinoma.
• The study discusses the potential role of MAb 1BE12 in guiding treatment decisions, such as laser ablation versus hysterectomy.